3rd Quarter - Termination

PHARMATHENE, INC for PHARMATHENE, INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$207,464
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Jul 1, 2008

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 23, 2008 $207,464 Replaced
3rd Quarter - Termination (this page) Aug 25, 2009 $207,464 Replaced
3rd Quarter - Amendment Oct 20, 2009 $207,464 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health & Human Services (HHS) anthrax vaccine and antitoxin. Avanced research and development. BARDA funding. Project Bioshield. Biodefense

LobbyistCovered position, as disclosed
MARK EDWARD COOKE —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.